title: T cell responses to the human papillomavirus type 16 E7 protein in mice of different haplotypes.
abstract: The response of murine T cells to the E7 molecule of human papillomavirus type 16 (HPV-16) was studied using eight different mouse strains of six distinct H-2 haplotypes. HPV-16 E7 protein was prepared as a fusion protein with glutathione-S-transferase, purified by affinity chromatography and used for immunization. Cells from the lymph nodes were cultured with whole fusion protein, glutathione-S-transferase or HPV-16 E7 protein synthetic peptides. All the mouse strains tested, with the exception of BALB/c, recognized the E7 molecule, as evidenced by a proliferative response to at least two of the peptides. The profile of responses to peptides varied between and within a strain, but five distinct immunodominant regions could be identified. These regions were defined on the basis of a reaction to one or more peptides in a given part of the E7 molecule by at least four strains. The five regions were encompassed by amino acid residues 1 to 9, 17 to 32, 42 to 59, 62 to 77 and 87 to 98. The findings suggest that in an outbred population, such as man, the E7 molecule of HPV-16 would be recognized by a large proportion of the population. However, the poor response of two mouse strains [B10.RIII (71NS) and BALB/c] could also have a corollary in man.
authors.affiliation: Department of Immunology, United Medical School, Guy's Hospital, London Bridge, U.K.
authors.forename: P S
authors.initials: PS
authors.lastname: Shepherd
authors.forename: T T
authors.initials: TT
authors.lastname: Tran
authors.forename: A J
authors.initials: AJ
authors.lastname: Rowe
authors.forename: J C
authors.initials: JC
authors.lastname: Cridland
authors.forename: S A
authors.initials: SA
authors.lastname: Comerford
authors.forename: M G
authors.initials: MG
authors.lastname: Chapman
authors.forename: L S
authors.initials: LS
authors.lastname: Rayfield
mesh_terms: D000818:Animals; D005982:Glutathione Transferase / Q000096:biosynthesis / Q000235:genetics; D006183:H-2 Antigens / Q000235:genetics / Q000276:immunology; D006239:Haplotypes; D008198:Lymph Nodes / Q000166:cytology / Q000276:immunology; D008213:Lymphocyte Activation / Q000276:immunology*; D051379:Mice; D009856:Oncogene Proteins, Viral / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology*; D027383:Papillomaviridae / Q000276:immunology*; D050725:Papillomavirus E7 Proteins; D010446:Peptide Fragments / Q000276:immunology; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*; D014611:Vaccination
chemical_list: D006183:H-2 Antigens; D009856:Oncogene Proteins, Viral; D050725:Papillomavirus E7 Proteins; D010446:Peptide Fragments; D011993:Recombinant Fusion Proteins; C059731:oncogene protein E7, Human papillomavirus type 16; D005982:Glutathione Transferase